Thyrocare Technologies Limited
NSE: THYROCARE.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Rahul Franklin Guha
- Employees
- 1,693
- Headquarters
- Navi Mumbai, India
- IPO year
- 2016
- Market cap
- ₹25.8B
- Website
- https://www.thyrocare.com
Loading THYROCARE…
Loading profile data…Frequently asked questions about THYROCARE
What does Thyrocare Technologies Limited (THYROCARE.NS) do?
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders an...
Where does THYROCARE.NS trade?
Thyrocare Technologies Limited (THYROCARE.NS) trades on the National Stock Exchange of India.
What sector is THYROCARE.NS in?
Thyrocare Technologies Limited (THYROCARE.NS) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Thyrocare Technologies Limited?
Rahul Franklin Guha is the chief executive officer of Thyrocare Technologies Limited (THYROCARE.NS).
Where is Thyrocare Technologies Limited headquartered?
Thyrocare Technologies Limited is headquartered in India.
Does THYROCARE.NS pay a dividend?
Yes — Thyrocare Technologies Limited (THYROCARE.NS) paid a trailing twelve-month dividend of INR 9.33 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did THYROCARE.NS go public?
Thyrocare Technologies Limited (THYROCARE.NS) completed its initial public offering in 2016.